BARCLAYS PLC/ GB0031348658 /
1/23/2025 10:21:09 AM | Chg. 0.00 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
294.00GBX | 0.00% | 70,548 Turnover(GBP): 207,097.3995 |
-Bid Size: - | -Ask Size: - | 44.47 bill.GBP | - | - |
GlobeNewswire
5/16/2024
DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors with Losses in E...
Newsfile Corp
5/8/2024
DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Barclays PLC Investors to Secure Counsel B...
GlobeNewswire
5/7/2024
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Important...
GlobeNewswire
4/29/2024
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
4/25/2024
ROSEN, A LEADING LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important Dead...
GlobeNewswire
4/21/2024
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Importan...
GlobeNewswire
4/8/2024
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Barclays PLC Investors to Secure Counsel Before Importan...
GlobeNewswire
4/5/2024
ROSEN, A LEADING NATIONAL FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important...
GlobeNewswire
3/31/2024
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
3/24/2024
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Imp...
GlobeNewswire
3/11/2024
Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference
GlobeNewswire
2/29/2024
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference